Overcoming therapeutic inertia with inhaled insulin

<p>In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation.</p><p>Key discussion points:</p><ul><li><p>Defining therapeutic inertia in the context of insulin initiation.</p></li><li><p>Common clinician and patient-related barriers that contribute to treatment delays.</p></li><li><p>Practical strategies for introducing inhaled insulin to hesitant patients.</p></li><li><p>System-level considerations, including workflow and reimbursement challenges.</p></li></ul><p>Find more resources and exclusive content on the ATTD Education Portal: <a href="https://unlok-education.com/attd/" rel="ugc noopener noreferrer" target="_blank">https://unlok-education.com/attd/</a></p><p>Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together.</p><p>#DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcast</p><p><strong>Chapters:</strong></p><p>00:00 Why Inhaled Insulin Matters</p><p>00:34 Show Intro and Guest</p><p>01:22 Defining Therapeutic Inertia</p><p>02:19 Clinician Barriers to Insulin</p><p>03:49 Patient Fears and Hesitation</p><p>05:28 How Inhaled Insulin Helps</p><p>07:00 Best Fit Patient Scenarios</p><p>08:22 Talking to Hesitant Patients</p><p>10:39 Workflow and Coverage Hurdles</p><p>13:35 PFT Testing and Side Effects</p><p>14:47 Future Role and Wrap Up</p><p><br /></p>